[Bladder cancer in geriatric patients].

IF 0.9
Medycyna pracy Pub Date : 2025-09-08 Epub Date: 2025-09-01 DOI:10.13075/mp.5893.01621
Tomasz Michalik, Michał Wróbel, Sebastian Adrian Fedorowicz, Karolina Michalik
{"title":"[Bladder cancer in geriatric patients].","authors":"Tomasz Michalik, Michał Wróbel, Sebastian Adrian Fedorowicz, Karolina Michalik","doi":"10.13075/mp.5893.01621","DOIUrl":null,"url":null,"abstract":"<p><p>Bladder cancer is one of the most commonly diagnosed cancers, especially in older people. Bladder cancer belongs to urothelial carcinomas, which can also occur in other parts of the urinary tract (also at the same time). The most common symptom of bladder cancer is hematuria. Bladder cancer treatment is largely based on surgery. Not all patients (due to comorbidities) will benefit from surgical treatment (especially in the case of radical cystectomy). Appropriate geriatric assessment of patients is crucial when qualifying for surgery. The aim of this article was to indicate the best management of a multimorbid geriatric patient with bladder cancer. The authors presented current knowledge and discussed interdisciplinary approach. The literature review included scientific articles that form the new standards and current guidelines of the European Association of Urology. Geriatric patients with bladder cancer require greater specialist involvement and multidisciplinary care. During qualification for treatment, close cooperation between urologist, oncologist, geriatrician, and other specialists is necessary. Due to the complex therapeutic process, not all patients will be able to follow all recommendations. Personalized medicine allows for the selection of the most appropriate therapeutic option. Further research is also needed on less invasive treatments, such as trimodal therapy, which includes transurethral resection of the bladder tumor, systemic chemotherapy, and external beam radiation therapy - especially for patients who are not eligible for radical treatment. Med Pr Work Health Saf. 2025;76(3):233-239.</p>","PeriodicalId":101460,"journal":{"name":"Medycyna pracy","volume":" ","pages":"233-239"},"PeriodicalIF":0.9000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medycyna pracy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.13075/mp.5893.01621","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Bladder cancer is one of the most commonly diagnosed cancers, especially in older people. Bladder cancer belongs to urothelial carcinomas, which can also occur in other parts of the urinary tract (also at the same time). The most common symptom of bladder cancer is hematuria. Bladder cancer treatment is largely based on surgery. Not all patients (due to comorbidities) will benefit from surgical treatment (especially in the case of radical cystectomy). Appropriate geriatric assessment of patients is crucial when qualifying for surgery. The aim of this article was to indicate the best management of a multimorbid geriatric patient with bladder cancer. The authors presented current knowledge and discussed interdisciplinary approach. The literature review included scientific articles that form the new standards and current guidelines of the European Association of Urology. Geriatric patients with bladder cancer require greater specialist involvement and multidisciplinary care. During qualification for treatment, close cooperation between urologist, oncologist, geriatrician, and other specialists is necessary. Due to the complex therapeutic process, not all patients will be able to follow all recommendations. Personalized medicine allows for the selection of the most appropriate therapeutic option. Further research is also needed on less invasive treatments, such as trimodal therapy, which includes transurethral resection of the bladder tumor, systemic chemotherapy, and external beam radiation therapy - especially for patients who are not eligible for radical treatment. Med Pr Work Health Saf. 2025;76(3):233-239.

[老年患者的膀胱癌]。
膀胱癌是最常见的癌症之一,尤其是在老年人中。膀胱癌属于尿路上皮癌,也可发生在尿路的其他部位(也同时发生)。膀胱癌最常见的症状是血尿。膀胱癌的治疗主要基于手术。并非所有患者(由于合并症)都能从手术治疗中获益(尤其是根治性膀胱切除术)。适当的老年患者评估是至关重要的,当有资格进行手术。这篇文章的目的是指出最好的管理多病老年患者膀胱癌。作者介绍了目前的知识,并讨论了跨学科的方法。文献综述包括形成欧洲泌尿外科协会新标准和现行指南的科学文章。老年膀胱癌患者需要更多的专家参与和多学科治疗。在获得治疗资格的过程中,泌尿科医生、肿瘤科医生、老年科医生和其他专家之间的密切合作是必要的。由于复杂的治疗过程,并非所有患者都能遵循所有建议。个性化医疗允许选择最合适的治疗方案。微创治疗也需要进一步的研究,如三模式治疗,包括经尿道膀胱肿瘤切除术、全身化疗和外部束放射治疗,特别是对于不符合根治性治疗条件的患者。医学Pr工作卫生安全,2025;76(3)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书